Vamorolone: Side Effects, Uses & Monitoring
Facts extracted from current FDA product labeling for Vamorolone. Educational only — not medical advice.
Labeled uses
AGAMREE is indicated for the treatment of Duchenne muscular dystrophy (DMD) in patients 2 years of age and older.
Source: FDA labeling via NIH DailyMed (set fb376f09…). Not affiliated with FDA or NIH.
Medical disclaimer: Always consult a qualified healthcare professional about any medication.